Illumina, Inc. (ILMN) Expected to Post Quarterly Sales of $825.07 Million


Equities research analysts expect Illumina, Inc. to report sales of $825.07 million for the current fiscal quarter, according to Zacks . Six analysts have provided estimates for Illumina's earnings, with the highest sales estimate coming in at $838.99 million and the lowest estimate coming in at $775.00 million.



from Biotech News